Dako North America, Inc. Company Profile
Oncogene Science, a part of Bayer HealthCare develops.Customer service for our products is provided by our distributor, Dako.NCI/NIH scientists established Oncogene Science, Inc. (OSI) in 1983 as a research and development organization focused on cancer and oncogenes. In 1991, OSI acquired Applied bioTechnology of Cambridge MA, which focused on the development and introduction of state-of-the-art diagnostic assays for in vitro diagnostic (IVD) and research-use-only (RUO) applications.In 1995, OSI sold its Research Products business to CN BioSciences in order to focus resources and efforts within its biopharmaceuticals and diagnostics core competencies. Presently, CN BioSciences operates this business as Oncogene Research Products, and continues to sell antibodies and probes to the research community. In 1997, Oncogene Science, Inc. changed its name to OSI Pharmaceuticals, Inc. (OSIP), and through a series of corporate partnerships, evolved Oncogene Science Diagnostics, Inc.(OSDI) into a wholly owned subsidiary of OSIP. On December 1, 1999, OSIP sold OSDI to the diagnostics business group of Bayer Corporation. Bayer Corporation is the U.S. holdings of Bayer AG headquartered in Leverkusen, Germany. Bayer, one of the largest medical diagnostics companies in the world, is focused to become the world leader in cancer diagnostics. Effective December 1, 1999, Oncogene Science Diagnostics assumed the trade name Oncogene Science
Location
6392 Via Real
Carpinteria
California
93013
United States of America
Contact
Phone: 1 805 566 6655
Fax: 1 805 566 6688
Email: customer.service.us@dako.com
News Articles
Dako, Panagene sign supply agreement for PNA oligomer component
Panagene announced it has signed a supply agreement with Dako Denmark A/S to supply PNA oligomer key component for incorporation into Dako's diagnostic or research products. Dako, an Agilent Technolog...
GLOSTRUP, Denmark, Jan. 7, 2013 - Dako, an Agilent Technologies company, announced today it has entered into a master framework agreement with Eli Lilly and Company for the development of companio...
Dako collaborates with Eli Lilly for companion diagnostics
Dako has entered into a master framework agreement with Eli Lilly and Company for the development of companion diagnostic tests to identify patients who may be more likely to benefit from an investiga...
Dako's companion diagnostics for Perjeta wins FDA OK
The FDA has granted Dako approval to market its HercepTest and HER2 FISH pharmDx as companion diagnostics for newly approved -More-
Dako strikes supply deal with S. Korean biotech firm
Panagene, a South Korean company, has agreed to supply Dako with its peptide nucleic acid probes for undisclosed terms. -More-
Dako Enters Collaboration With Lilly For Development Of Companion Diagnostics
SANTA CLARA (dpa-AFX) - Dako, an Agilent Technologies Inc. (A) company, announced Monday that it has entered into a master framework agreement with Eli Lilly and Co. (LLY) for the development of c...
Dako, Pfizer team up for companion diagnostics
Denmark-based cancer diagnostics solutions manufacturer Dako announced that it has entered into collaboration agreement with Pfizer in the field of companion diagnostics.
GLOSTRUP, DENMARK -- (Marketwire) -- 03/05/13 -- Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, announced today it has received approval from the U.S. Food and Dr...
Drugs and Medications
Tork premium [SCA Tissue North America]
TORK® Soap Foam Antibacterial
Tork premium hand sanitizer foam [SCA Tissue North America]
TORK Hand Sanitizer Foam
Tork premium hand sanitizer foam alcohol-free [SCA Tissue North America]
TORK® Hand Sanitizer Foam Alcohol-Free
Tork advanced antimicrobial [SCA Tissue North America]
Drug Facts
Pro therapy md [Valeant Pharmaceuticals North America LLC]
PRO+ THERAPY MD™ ADVANCED ULTRA LIGHT DAY REPAIR SPF 30
PubMed Articles
Background: Sensitization to weed pollen allergens at the molecular level is not fully understood. We studied IgE reactivity to the major mugwort allergen Art v 1 in relation to allergens from other w...
NORTH AMERICA AND SOUTH AMERICA (NA-SA) NEUROPATHY PROJECT.
Abstract Peripheral neuropathy is a common neurological disorder. There may be important differences and similarities in the diagnosis of peripheral neuropathy between North America (NA) and South Ame...
An emerging disease causes regional population collapse of a common North American bat species.
White-nose syndrome (WNS) is an emerging disease affecting hibernating bats in eastern North America that causes mass mortality and precipitous population declines in winter hibernacula. First discove...
The woodpecker genus Colaptes (flickers) has its highest diversity in South America and the closely related genus Piculus is restricted to South and Central America. Two species of flickers occur in N...
Clinical Trials
Sorafenib-RT in Treating Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. The incidence is highest in Asia and it is increasing in North America, with a two to three fold increase in mor...
Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin
This trial will be conducted in Africa, Asia, North America and South America. The aim of this clinical trial is to compare NN1250 with sitagliptin, as add-on to subject's own current oral...
This trial was conducted in Europe, Middle East, North America and South America. The aim of this trial was to compare the use of an intensified insulin treatment Insulin Aspart (NovoRapi...
CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography
CNV from AMD is the leading cause of blindness in people over 50 in North America. The hypothesis is to determine if there is an improvement in retinal function determined by ERG following...
Obese Patients With or Without Comorbidities (RIO-North America)
To assess the effects of weight loss and weight maintenance over a period of two years when prescribed with a hypocaloric diet in obese patients with or without comorbidities
Companies
Identification of the origins of tumors and other diseases in body tissues has made great strides over the past two decades. As researchers expand their knowledge of cellular antigens and how these an...
JMS North America (JMSNA) was established as a wholly owned subsidiary of JMS Co., Ltd., one of the largest Japanese medical device companies, in March 1993. Now JMSNA's headquarters is located in Hay...
Oncogene Science, a part of Bayer HealthCare develops.Customer service for our products is provided by our distributor, Dako.NCI/NIH scientists established Oncogene Science, Inc. (OSI) in 1983 as a re...
Zurich in North America is a part of Zurich Financial Services Group (Zurich), an insurance-based financial services provider with a global network of subsidiaries and offices in...
Dako is one of the world's leading companies in cancer diagnostics. We are devoted to helping pathologists by improving their ability to diagnose cancer. To do this, we develop, manufacture and market...
More Information about "Dako North America, Inc." on BioPortfolio
We have published hundreds of Dako North America, Inc. news stories on BioPortfolio along with dozens of Dako North America, Inc. Clinical Trials and PubMed Articles about Dako North America, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dako North America, Inc. Companies in our database. You can also find out about relevant Dako North America, Inc. Drugs and Medications on this site too.
